Skip to main content
Premium Trial:

Request an Annual Quote

Proteomics Sandia's Biotech Initiative Going Strong, with Proteomics Niche


Sandia National Laboratories’ recent announcement of its new biotech initiative was more self-affirmation than news. But it does prove that a little advance planning can go a long way. The initiative, a strategy for rounding up Sandia’s scattered biology efforts and coordinating them, started in April of 1999 at “a half-day meeting of the senior management,” according to Len Napolitano, acting director in Sandia’s biosystems research department.

“At the beginning, it was more or less a gleam in the eye of Sandia leadership,” agrees Julia Phillips, director of the physical and chemical sciences center. By now, the initiative has seen a measure of success. Sandia scored the lead role in a collaboration for the DOE’s Genomes to Life project and is working on several of the other partnerships for the project.

“Proteomics is ultimately where this is all leading,” explains Danny Rintoul, manager of the computational biology department.

Sandia has also flexed its muscles with a microarray project and plans to develop proteomics instruments to work toward systems biology, Napolitano says. And now that bioterror applications have become such a prominent component of genomics and proteomics, he adds that the labs are “looking at protein signatures in organisms … to do detection of proteins or biotoxins that might be used as biological warfare agents.”

That said, Sandia has no illusions that it will transform itself purely to biology. “Sandia itself will not be the dominant player in biotech,” Napolitano says. “There are very few of these biology projects that we’re working on that don’t have a partner” — a university or another lab, for instance.

“There is no one person or even one institution that could possibly do the whole thing, or even a large chunk of it,” says Phillips.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.